What is it about?
This study looked at a potential new way to treat uneven jaw growth in young patients. The researchers injected a growth-promoting substance called IGF-1 into one side of the jaw joint in mice. They found that this caused extra growth only on the injected side, without affecting the rest of the body. The mice that received the injection developed slightly lopsided jaws, with more growth on the treated side. This suggests that targeted IGF-1 injections could potentially be used to stimulate growth on the smaller side of the jaw in patients with facial asymmetry. Importantly, the treatment seemed safe, with no negative effects observed in other parts of the body or overall mouse growth. However, the researchers emphasize that much more testing is needed in larger animals and eventually humans before this could become a real treatment option. If further studies prove successful, this method could offer a new way to help correct uneven jaw growth in young patients without requiring invasive surgery. But for now, it remains an early experimental approach that needs a lot more research.
Featured Image
Why is it important?
This study introduces a novel approach to treating mandibular asymmetry, which is both unique and timely for several reasons: 1. Targeted local treatment: Unlike systemic treatments or invasive surgical procedures, this method uses targeted local injections of IGF-1. This approach minimizes potential side effects while maximizing the impact on the desired area. 2. Non-invasive alternative: Current treatments for mandibular asymmetry often involve invasive surgeries or lengthy orthodontic treatments. This method could potentially offer a less invasive alternative, which is particularly beneficial for younger patients. 3. Precision medicine approach: By allowing for controlled, unilateral growth stimulation, this method represents a step towards more personalized treatment options in orthodontics and maxillofacial surgery. 4. Addressing a common issue: Mandibular asymmetry is a relatively common condition that can significantly impact facial aesthetics and dental function. This research addresses an important clinical need. 5. Bridging basic science and clinical application: This study demonstrates how insights from basic science (understanding the role of IGF-1 in bone growth) can be translated into potential clinical applications. 6. Future research directions: This work opens up new avenues for research in craniofacial development and treatment, potentially inspiring further studies in larger animal models and eventually human clinical trials. The potential impact of this research is significant. If further developed and proven safe and effective in humans, this approach could: - Provide orthodontists and maxillofacial surgeons with a new tool for treating mandibular asymmetry - Reduce the need for invasive surgical procedures in some cases - Improve treatment outcomes and patient satisfaction - Potentially be adapted for other localized bone growth disorders While still in early stages, this research represents an important step towards developing more targeted, less invasive treatments for craniofacial asymmetries, which could significantly improve patient care in the future.
Perspectives
As the lead researcher on this study, I'm excited about the potential implications of our findings, but I also want to emphasize the preliminary nature of this work. Here's my personal perspective: This project grew out of a longstanding interest in finding less invasive ways to treat craniofacial asymmetries, particularly in young patients. As an orthodontist, I've seen firsthand how challenging these cases can be - both physically and emotionally for patients. The idea of using localized growth factor injections was intriguing to me because it offered the possibility of a more targeted approach. I was genuinely surprised by how effective the unilateral IGF-1 injections were in stimulating localized growth. While we had hypothesized this effect, seeing the clear asymmetry develop in our mouse models was quite striking. It really drove home the potential this approach could have. That said, I want to be very clear that we are still in the early stages of this research. Mouse models, while useful, are a long way from human clinical applications. There are many questions we still need to answer about long-term effects, optimal dosing, and potential risks. I'm also acutely aware of the ethical considerations involved in developing treatments that alter facial growth and appearance, especially in young patients. As we move forward with this research, it will be crucial to carefully consider these ethical implications. Personally, I'm most excited about how this work might open up new avenues of research in craniofacial development. Even if this specific approach doesn't pan out as a clinical treatment, I believe the insights we gain could lead to other innovative approaches in the future. Overall, while I'm optimistic about the potential of this work, I'm also cautious. We have a long road ahead before this could become a viable treatment option. But I'm committed to continuing this line of research, as I believe it holds real promise for improving patient care in the long run.
Hiroyuki Kanzaki
Tsurumi University
Read the Original
This page is a summary of: Possible alternative treatment for mandibular asymmetry by local unilateral IGF-1 injection into the mandibular condylar cavity: Experimental study in mice, American Journal of Orthodontics and Dentofacial Orthopedics, December 2017, Elsevier,
DOI: 10.1016/j.ajodo.2017.05.023.
You can read the full text:
Contributors
The following have contributed to this page
